Post Subject #793   13th Global Drug Delivery & Formulation Summit RealFooFighters 05/19/22 07:51:18 AM #792   Always a good sign when the TOP DOGS dhbuzz 05/13/22 08:37:54 AM #791   May Presentation RealFooFighters 05/12/22 10:55:00 PM #790   BioNTech Deal… RealFooFighters 05/12/22 10:53:24 PM #789   MAT2203 Update RealFooFighters 05/12/22 10:52:29 PM #788   LNC Remdesivir Update RealFooFighters 05/12/22 10:50:32 PM #787   Conviction Thesis (checking the boxes): RealFooFighters 05/06/22 10:40:36 PM #786   MTNB will be $3 soon. A good stock, vdt 05/03/22 11:51:38 AM #785   https://www.nasdaq.com/articles/thinking-of-buying-biontech-consider-these-3-thi dhbuzz 04/30/22 12:28:05 PM #784   I expect big things for MTNB's share price The Lawman 04/29/22 02:13:51 PM #783   https://www.biospace.com/article/biontech-joins-ranks-of-largest-drugmakers-in-t dhbuzz 04/16/22 02:48:09 PM #782   https://www.biospace.com/article/new-licensing-and-collaboration-deals-in-life-s dhbuzz 04/15/22 11:24:45 AM #781   Very impressive. THANKS RFF dhbuzz 04/14/22 01:06:52 PM #780   Updated Presentation (April) RealFooFighters 04/14/22 06:52:21 AM #779   Needham Webcast w/CEO Jabbour (4/13/22) RealFooFighters 04/14/22 06:50:45 AM #778   Matinas Biopharma News vdt 04/11/22 10:10:21 PM #777   https://ih.advfn.com/stock-market/AMEX/matinas-biopharma-MTNB/stock-news/8780233 dhbuzz 04/11/22 11:12:16 AM #776   Matinas BioPharma to Present at the Needham Virtual RealFooFighters 04/06/22 07:25:40 AM #775   https://www.verywellhealth.com/what-does-in-vivo-and-in-vitro-mean-2249118 dhbuzz 04/05/22 11:05:07 PM #774   Oral remdesivir update (CEO Jabbour - Maxim Virtual RealFooFighters 03/29/22 10:05:53 AM #773   Matinas BioPharma to Participate in the 2022 Virtual RealFooFighters 03/22/22 07:51:15 AM #772   https://nano-magazine.com/news/2022/3/21/nanocarriers-based-on-nucleic-acids-an- dhbuzz 03/21/22 06:57:28 AM #771   Thanks RFF dhbuzz 03/21/22 06:50:57 AM #770   Some cc excerpts (CEO Jabbour - Mar 8) RealFooFighters 03/20/22 12:05:12 AM #769   EnACT Cohort 4 initial enrollees now crossing 30 RealFooFighters 02/17/22 11:48:46 AM #768   https://www.msn.com/en-us/news/world/vaccine-scientists-have-been-chasing-varian dhbuzz 02/14/22 11:45:47 PM #767   Interview with CEO Jerome D. Jabbour RealFooFighters 02/13/22 09:08:47 AM #766   Moderna news may have joLted MTMB TODAY A TAD. dhbuzz 01/28/22 10:19:23 PM #765   $MTNB looking good, going UP vdt 01/28/22 03:45:26 PM #764   Looking Good !eom dhbuzz 01/26/22 06:44:15 PM #763   Matinas BioPharma Provides Business Update and 2022 Strategic Outlook RealFooFighters 01/25/22 02:41:03 PM #762   GL! RealFooFighters 01/24/22 10:28:39 PM #761   Yea nice posts from you thanks Realcool11 01/24/22 10:27:25 PM #760   You read my previous post! RealFooFighters 01/24/22 10:26:35 PM #759   Seems they will announce a reverse split since Realcool11 01/24/22 10:18:37 PM #758   Save the date - Matinas BioPharma to Provide RealFooFighters 01/23/22 10:07:14 PM #757   Save the date - Matinas BioPharma to Provide RealFooFighters 01/23/22 10:05:47 PM #756   Excellent analysis RealFoo. The Lawman 01/23/22 05:45:00 PM #755   Conviction that they check all the boxes: RealFooFighters 01/23/22 04:14:16 PM #754   Getting interesting! RealFooFighters 01/23/22 04:10:21 PM #753   Tuesday’s 2022 update, lot’s of moving parts, some stuff: RealFooFighters 01/23/22 04:06:10 PM #752   Check out Gilead press release on phase 1 specopsman 01/22/22 04:42:50 PM #751   Friday was a VERY INTERESTING trade day,is something dhbuzz 12/18/21 10:00:29 AM #750   December 16 2021 - 06:30AM dhbuzz 12/16/21 07:04:04 AM #749   WATCH VERY CLOSELY dhbuzz 12/08/21 07:53:12 PM #748   https://humanevents.com/2021/12/01/remdesivir-expected-to-remain-effective-again dhbuzz 12/02/21 06:55:26 AM #747   WELCOME DECEMBER ! dhbuzz 12/01/21 07:28:07 AM #746   Heavy duty pre market...more news in the works??? dhbuzz 11/10/21 07:58:50 AM #745   Yes, MTNB will have substantial movement UP vdt 11/05/21 03:16:26 PM #744   Its been a slow ride now for a dhbuzz 10/27/21 09:21:37 AM Post Subject

© 2022 InvestorsHub.com, Inc.